SESOTHO trial ("Switch Either near Suppression Or THOusand") - switch to second-line versus WHO-guided standard of care for unsuppressed patients on first-line ART with viremia below 1000 copies/mL: protocol of a multicenter, parallel-group, open-label, randomized clinical trial in Lesotho, Southern Africa.
Alain AmstutzBienvenu Lengo NsakalaFiona VanobberghenJosephine MuhairweTracy Renée GlassBeatrice AchiengMamorena SepekaKatleho TlaliLebohang SaoKyaw ThinThomas KlimkaitManuel BattegayNiklaus Daniel LabhardtPublished in: BMC infectious diseases (2018)
ClinicalTrials.gov ( NCT03088241 ), registered May 05, 2017.
Keyphrases
- open label
- end stage renal disease
- clinical trial
- ejection fraction
- phase iii
- phase ii
- newly diagnosed
- healthcare
- study protocol
- chronic kidney disease
- randomized controlled trial
- peritoneal dialysis
- double blind
- quality improvement
- hiv infected
- squamous cell carcinoma
- radiation therapy
- patient reported outcomes
- phase ii study